Skip to main content
Evome Medical Technologies Inc. logo

Evome Medical Technologies Inc. — Investor Relations & Filings

Ticker · EVMT ISIN · CA30053H1055 TSXV Manufacturing
Open in API
Filings indexed 403 across all filing types
Latest filing 2024-05-18 Major Shareholding Noti…
Country CA Canada
Listing TSXV EVMT

About Evome Medical Technologies Inc.

https://www.evomemedical.com

Evome Medical Technologies Inc. is a medical device enterprise dedicated to the design, development, production, and distribution of specialized medical devices. The company's core business centers on human performance and rehabilitative solutions, specifically addressing the post-operative and recovery market. Evome aims to enhance patient outcomes through its portfolio of devices utilized in rehabilitation settings.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Major Shareholding Notification Classification · 95% confidence The document is titled 'EARLY WARNING REPORT NEWS RELEASE' and discusses a filing by Michael Dalsin regarding his holdings in Evome Medical Technologies Inc. It references a decrease in shareholding percentage and mentions the filing of an early warning report (Form 62-103F1). The content focuses on changes in significant share ownership levels and compliance with securities laws. There is no detailed financial data, management discussion, or report publication. This fits the definition of a Major Shareholding Notification, which involves notification of changes in significant share ownership levels crossing thresholds.
2024-05-18 English
Other.pdf
Regulatory Filings Classification · 100% confidence The document is a Form 6-K filed by Evome Medical Technologies Inc., which is a report of a foreign private issuer pursuant to SEC rules. It contains no financial statements or substantive financial data but rather provides information about the company's foreign private issuer status and related regulatory disclosures. The document is short (2773 characters) and primarily serves as a regulatory filing to inform about the company's status and reporting intentions. It does not contain an annual report, interim report, earnings release, or any other detailed financial or management information. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other categories.
2024-04-23 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Exhibit 31.1' and contains a certification statement by the CEO regarding the accuracy and completeness of the Annual Report on Form 10-K for Evome Medical Technologies Inc. The text focuses on attesting to the reliability of the financial statements and internal controls, referencing Exchange Act Rules related to disclosure controls and internal control over financial reporting. There is no actual financial data or detailed report content present; rather, it is a formal officer certification related to the 10-K filing. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS) rather than the Annual Report (10-K) itself.
2024-04-17 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 95% confidence The document is a Management Certification related to Form 13-502F1, which is a regulatory form submitted to the Ontario Securities Commission concerning participation fees for reporting issuers. It includes detailed calculations of market values and fees payable but does not contain financial statements or substantive financial data typical of annual or quarterly reports. The document is primarily a certification by an officer (Chief Financial Officer) attesting to the accuracy and completeness of the information provided in the form. Given the nature of the document as a certification and regulatory submission rather than a financial report or announcement, it fits best under Regulatory Filings (RNS).
2024-04-17 English
Annual MD&A - English.pdf
Annual Report Classification · 100% confidence The document is titled 'FORM 10-K' and is described as an 'ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the fiscal year ended December 31, 2023. It includes detailed sections typical of a 10-K filing such as Business Overview, Risk Factors, Management's Discussion and Analysis, Financial Statements, and Signatures. The length of the document (15,000 characters) and the presence of substantive financial and operational information confirm it is the full annual report, not just an announcement or summary. Therefore, the appropriate classification is Annual Report (10-K). FY 2023
2024-04-17 English
Audited annual financial statements – English.pdf
Annual Report Classification · 100% confidence The document is titled 'FORM 10-K' and is described as an 'ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the fiscal year ended December 31, 2023. It includes detailed sections typical of an annual report such as business overview, risk factors, management's discussion and analysis, financial statements, and exhibits. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of detailed company information, fiscal year dates, and comprehensive content confirms this is the official annual report filing (10-K). FY 2023
2024-04-17 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.